Bausch Health (BHC) President Aimee J. Lenar Sells Shares

What Happened
Aimee J. Lenar, President, US Pharmaceuticals at Bausch Health (BHC), sold 36,827 shares of Bausch Health common stock on August 19, 2026. The shares were sold at $7.03 each, generating proceeds of approximately $258,894. This was a sale (code S) rather than a purchase—sales by executives are often routine and do not necessarily indicate a change in company outlook.

Key Details

• Transaction date: August 19, 2026; sale price: $7.03 per share; total proceeds: ~$258,894.
• Transaction type: Open-market sale (SEC code S).
• Footnote: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2026.
• Shares owned after the transaction: not specified in the provided filing.
• Filing date: August 20, 2026 (filed the next day), which is within the typical Form 4 reporting window.

Context
Sales executed under a Rule 10b5-1 plan are pre-scheduled trading arrangements that allow insiders to sell shares at predetermined times; such sales are generally considered routine and may reflect pre-set personal liquidity plans rather than a view on the company. For retail investors, purchases by insiders tend to be more informative than routine sales.